G20 meeting live updates: Bessent, Warsh kick off summit with growth-focused remarks
Treasury Secretary Scott Bessent and Federal Reserve Chairman Kevin Warsh christened Monday’s gathering of the Group of 20…
Stock market today: Live updates
Traders work on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., August…
Eli Lilly will file for approval of retatrutide obesity drug in 2027
The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025. Mike Blake…
Trump plans high generic-drug tariffs in 2028 to spur U.S. production
U.S. President Donald Trump signs an executive order on researching the effects of psychedelic drugs in medical treatment…
Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion
The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025. Mike Blake…
Medicare obesity drug GLP-1 coverage starting July 1
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage…
Cramer: The data center is suddenly suspect. Can Big Tech fix it?
I sure didn’t want what happened to occur, at least not during my vacation, of all things. But it…
Iran’s neighbor, U.S. ally: What Pakistan gains from being a peacemaker
Pakistan’s Prime Minister Shehbaz Sharif (R) greets US Vice President JD Vance prior to a quadrilateral meeting between…
CVS restores Zepbound coverage, adds Eli Lilly’s obesity pill Foundayo
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on…
White House adds generic drugs to direct-to-consumer TrumpRx site
President Donald Trump speaks to introduce the TrumpRx website in the South Court Auditorium of the White House…
Stock market today: Live updates
Traders work on the floor of the New York Stock Exchange (NYSE) during Pershing Square Capital Management LP’s…
Eli Lilly to acquire cancer drug maker Kelonia in deal worth up to $7B
Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company…